Experimental antibiotic treatment for Lyme disease heads for human safety trials
Human safety trials of a novel antibiotic treatment for Lyme disease developed by Northeastern professor Kim Lewis are scheduled to start this spring in Australia, with results anticipated by fall.
Feb 29, 2024
0
1